Literature DB >> 11409906

Cancer and thrombosis revisited.

R Hoffman1, N Haim, B Brenner.   

Abstract

Remarkable progress has been made since the first description of the association between cancer and thrombosis by Trousseau over 100 years ago. Now, it is clear that there is a two-way connection between coagulation and cancer as tumor results in alterations in hemostatic balance, and thrombosis may promote tumor cell growth. A variety of clinical thrombotic syndromes may present in cancer patients including local and systemic venous and arterial thromboses. More evidence is now being gathered on the potential of antithrombotic regimens to prolong survival of cancer patients. Whether the use of novel antithrombotic drugs may result in a better outcome remains to be determined. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409906     DOI: 10.1054/blre.2001.0149

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  7 in total

Review 1.  Epidemiology and pathophysiology of cancer-associated thrombosis.

Authors:  S Noble; J Pasi
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

Review 2.  Activation of blood coagulation in cancer: implications for tumour progression.

Authors:  Luize G Lima; Robson Q Monteiro
Journal:  Biosci Rep       Date:  2013-09-04       Impact factor: 3.840

Review 3.  Cancer-associated thrombosis: an overview.

Authors:  Ghaleb Elyamany; Ali Mattar Alzahrani; Eman Bukhary
Journal:  Clin Med Insights Oncol       Date:  2014-12-04

Review 4.  Targeting Selectins and Their Ligands in Cancer.

Authors:  Alessandro Natoni; Matthew S Macauley; Michael E O'Dwyer
Journal:  Front Oncol       Date:  2016-04-18       Impact factor: 6.244

5.  Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery.

Authors:  M Byrne; J V Reynolds; J S O'Donnell; M Keogan; B White; M Byrne; S Murphy; S G Maher; G P Pidgeon
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

6.  In vitro effects of Apixaban on 5 different cancer cell lines.

Authors:  Luigina Guasti; Alessandro Squizzato; Paola Moretto; Davide Vigetti; Walter Ageno; Francesco Dentali; Andrea M Maresca; Leonardo Campiotti; Anna M Grandi; Alberto Passi
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

7.  Relationship between platelet-based models and the prognosis of patients with malignant hepatic tumors.

Authors:  Chen-Liang Hu; Qian-Cheng Du; Zhi-Xin Wang; Ming-Quan Pang; Yan-Yan Wang; Ying-Yu Li; Ying Zhou; Hai-Jiu Wang; Hai-Ning Fan
Journal:  Oncol Lett       Date:  2020-01-17       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.